These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26763003)

  • 1. Rifampin-sirolimus-voriconazole interaction in a hematopoietic cell transplant recipient.
    Wasko JA; Westholder JS; Jacobson PA
    J Oncol Pharm Pract; 2017 Jan; 23(1):75-79. PubMed ID: 26763003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus and mirabegron interaction in a hematopoietic cell transplant patient.
    Engle JA; Fair C
    J Oncol Pharm Pract; 2018 Dec; 24(8):627-631. PubMed ID: 28814193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
    Marty FM; Lowry CM; Cutler CS; Campbell BJ; Fiumara K; Baden LR; Antin JH
    Biol Blood Marrow Transplant; 2006 May; 12(5):552-9. PubMed ID: 16635790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT.
    Ceberio I; Dai K; Devlin SM; Barker JN; Castro-Malaspina H; Goldberg JD; Giralt S; Adel NG; Perales MA
    Bone Marrow Transplant; 2015 Mar; 50(3):438-43. PubMed ID: 25599164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.
    Törlén J; Ringdén O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itälä-Remes M; Remberger M; Mattsson J
    Haematologica; 2016 Nov; 101(11):1417-1425. PubMed ID: 27662016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous cyclosporine-rifampin interaction in a pediatric bone marrow transplant recipient.
    Zelunka EJ
    Pharmacotherapy; 2002 Mar; 22(3):387-90. PubMed ID: 11898895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of lansoprazole and rabeprazole on the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients.
    Yasu T; Konuma T; Kato S; Kurokawa Y; Takahashi S; Tojo A
    Ann Hematol; 2016 Oct; 95(11):1845-51. PubMed ID: 27535751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of isavuconazole on tacrolimus and sirolimus serum concentrations in allogeneic hematopoietic stem cell transplant patients: A drug-drug interaction study.
    Kieu V; Jhangiani K; Dadwal S; Nakamura R; Pon D
    Transpl Infect Dis; 2019 Feb; 21(1):e13007. PubMed ID: 30295407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
    Peksa GD; Schultz K; Fung HC
    J Oncol Pharm Pract; 2015 Dec; 21(6):409-15. PubMed ID: 24938293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible correlation of sirolimus plasma concentration with sinusoidal obstructive syndrome of the liver in patients undergoing myeloablative allogeneic hematopoietic cell transplantation.
    Kiel PJ; Vargo CA; Patel GP; Rosenbeck LL; Srivastava S
    Pharmacotherapy; 2012 May; 32(5):441-5. PubMed ID: 22499411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus-itraconazole interaction in a hematopoietic stem cell transplant recipient.
    Said A; Garnick JJ; Dieterle N; Peres E; Abidi MH; Ibrahim RB
    Pharmacotherapy; 2006 Feb; 26(2):289-95. PubMed ID: 16466336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patient.
    Lecefel C; Eloy P; Chauvin B; Wyplosz B; Amilien V; Massias L; Taburet AM; Francois H; Furlan V
    J Clin Pharm Ther; 2015 Feb; 40(1):119-20. PubMed ID: 25417855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole Autoinduction and Saturable Metabolism After Cessation of Rifampin in a Patient With Invasive Central Nervous System Aspergillus: Importance of Therapeutic Drug Monitoring.
    Farrokh S; Avdic E
    J Pharm Pract; 2019 Oct; 32(5):589-594. PubMed ID: 29495916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
    Rosenbeck LL; Kiel PJ; Kalsekar I; Vargo C; Baute J; Sullivan CK; Wood L; Abdelqader S; Schwartz J; Srivastava S; Abonour R; Robertson MJ; Nelson RP; Cornetta K; Fausel CA; Farag SS
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):916-22. PubMed ID: 20932925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clotrimazole troches induce supratherapeutic blood levels of sirolimus and tacrolimus in an allogeneic hematopoietic cell-transplant recipient resulting in acute kidney injury.
    El-Asmar J; Gonzalez R; Bookout R; Mishra A; Kharfan-Dabaja MA
    Hematol Oncol Stem Cell Ther; 2016 Dec; 9(4):157-161. PubMed ID: 26684920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants.
    Kubiak DW; Koo S; Hammond SP; Armand P; Baden LR; Antin JH; Marty FM
    Biol Blood Marrow Transplant; 2012 Sep; 18(9):1462-5. PubMed ID: 22564264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
    Ahmad NM; Rojtman AD
    Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease.
    Pidala J; Kim J; Alsina M; Ayala E; Betts BC; Fernandez HF; Field T; Jim H; Kharfan-Dabaja MA; Locke FL; Mishra A; Nishihori T; Ochoa-Bayona L; Perez L; Riches M; Anasetti C
    Haematologica; 2015 Jul; 100(7):970-7. PubMed ID: 25840599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation.
    Teusink A; Vinks A; Zhang K; Davies S; Fukuda T; Lane A; Nortman S; Kissell D; Dell S; Filipovich A; Mehta P
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):482-6. PubMed ID: 26616742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.